Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2017 / Article

Research Article | Open Access

Volume 2017 |Article ID 1231820 | 10 pages | https://doi.org/10.1155/2017/1231820

An Exploration of Traditional Chinese Medicinal Plants with Anti-Inflammatory Activities

Academic Editor: Daniela Rigano
Received16 Jan 2017
Revised27 Feb 2017
Accepted01 Mar 2017
Published04 Apr 2017

Abstract

In a continuing effort to discover more anti-inflammatory medicinal plants in China, the anti-inflammatory activities of 101 extracts from different parts of 84 traditional medicinal plants were evaluated by a panel of in vitro and in vivo assays. Nuclear factor-kappa B (NF-κB) inhibitory effects were determined by luciferase assay in stably transfected Hela cells. Cytotoxic activities were assessed using the MTT assay. Inhibitory effects on LPS-induced nitric oxide production and proinflammatory mediators were assessed by Griess reaction and Real-Time PCR analysis, respectively. In vivo anti-inflammatory activities were examined by xylene-induced mice ear edema model. In total, 22 extracts showed promising NF-κB inhibitory effects whereas 9 of them did not affect the cell viability. The 9 hit extracts were active in at least one of the subsequently performed in vitro pharmacological test systems. The extract from Hemerocallis minor (root) was selected to perform the in vivo study because it demonstrated significant suppressive effects in all the in vitro assays. Results showed that the extract of Hemerocallis minor (Root) was able to alleviate ear edema effectively in xylene-induced mice ear edema mode. Collectively, our study provides evidence for the potential anti-inflammatory effects of the medicinal plants traditionally used in China. Further phytochemical and pharmacological studies remain to be clarified.

1. Introduction

Inflammation is an adaptive response of body tissues to external challenge or cellular injury. It is generally thought that inflammation is a beneficial host response defense system, but it can become harmful if dysregulated [1]. The complex mediators including proinflammatory and cytotoxic cytokines, growth factors, bioactive lipids, and nitric oxide in the uncontrolled inflammation reaction can sustain or induce a pathologic process involved in different diseases, such as allergy, sepsis, arthritis, the metabolic syndrome, autoimmune diseases, and cancer [2]. The inhibition of inflammatory mediators on the transcriptional level has emerged as a promising approach for the development of anti-inflammatory drugs [3]. Nuclear transcription factor-kappa B (NF-κB) plays a key role among the involved transcription factors to regulate various genes involved in immune and acute phase inflammatory responses. The activation of NF-κB induces the transcriptions of iNOS, COX-2, TNF-α, and proinflammatory cytokines [4, 5]. Therefore, the NF-κB signaling pathway has long been considered the “holy grail” as a target for anti-inflammatory drug [3].

Traditional Chinese medicinal plants work well for many diseases and have been used for centuries in China. Its increasing use in recent years is evidence of a public interest in having alternatives to conventional medicine [6]. A variety of medicinal plants have been reported to have anti-inflammatory properties. However, a comprehensive investigation on exploring more anti-inflammatory medicinal plants and their action mode is lacking. In a continuing effort to discover more medicinal plants with anti-inflammatory effects in China, 101 extracts from different parts of 84 TCMs (Table 1) were screened for their potential inhibitory activities on NF-κB activation. In order to further determine their anti-inflammatory activity, the inhibition of the proinflammatory cytokines (TNF-α, IL-6, and IL-1β) or the NO production induced in LPS-stimulated murine RAW 264.7 was investigated. Mouse ear edema assay was used to verify the in vivo anti-inflammatory activity of the selected plant extracts.


NumberLatin namePlant partSample location

(1)Rehderodendron macrocarpumStemLushan, Jiangxi
(2)Styrax suberifoliaStemZhangjiajie, Hunan
(3)Alangium chinenseRootShijiazhuang, Hebei
(4)Alangium chinenseStemChengdu, Sichuan
(5)Alangium chinense ssp. triangulareRootJingzhou, Hubei
(6)Alangium chinense ssp. triangulareStemJingzhou, Hubei
(7)Alangium kurziiRootLushan, Jiangxi
(8)Alangium kurziiStemLushan, Jiangxi
(9)Alangium kurzii var. handeliiLeafLushan, Jiangxi
(10)Alangium kurzii var. handeliiRootLushan, Jiangxi
(11)Alangium platanifoliumLeafLushan, Jiangxi
(12)Alangium platanifoliumRootLushan, Jiangxi
(13)Alangium kurzii var. umbellatumStemLushan, Jiangxi
(14)Musa acuminataLeafXishuangbanna, Yunnan
(15)Musa balbisianaFlowerJingzhou, Hubei
(16)Musa balbisianaRootYunwushan, Guangdong
(17)Musa basjooStemJingzhou, Hubei
(18)Musa basjooFlowerShanghai
(19)Musa basjooLeafXishuangbanna, Yunnan
(20)Musa nanaLeafXishuangbanna, Yunnan
(21)Musa paradisiacaFlowerYunwushan, Guangdong
(22)Musella lasiocarpaHerbShanghai
(23)Ravenala madagascariensisLeafXishuangbanna, Yunnan
(24)Capparis acutifoliaHerbBozhou, Anhui
(25)Capparis bodinieriHerbChengdu, Sichuan
(26)Capparis masaikaiFruitShijiazhuang, Hebei
(27)Cleome gynandraSeedsShijiazhuang, Hebei
(28)Ceratostigma minusHerbChengdu, Sichuan
(29)Limonium bicolorHerbChengdu, Sichuan
(30)Plumbago zeylanicaHerbXishuangbanna, Yunnan
(31)Stemona sessilifoliaRootShanghai
(32)Aletris spicataHerbChengdu, Sichuan
(33)Allium macrostemonStemShanghai
(34)Allium tuberosumSeedsShanghai
(35)Aloe veraLeafShanghai
(36)Anemarrhena asphodeloidesRootShanghai
(37)Asparagus cochinchinensisRootShanghai
(38)Asparagus dauricusLeafXishuangbanna, Yunnan
(39)Asparagus filicinusHerbShanghai
(40)Aspidistra caespitosaLeafLushan, Jiangxi
(41)Aspidistra luridaHerbChengdu, Sichuan
(42)Aspidistra omeiensisLeafEmeishan, Sichuan
(43)Aspidistra omeiensisRootEmeishan, Sichuan
(44)Aspidistra typicaLeafShanghai
(45)Allium victorialisHerbShijiazhuang, Hebei
(46)Cardiocrinum cathayanumHerbLushan, Jiangxi
(47)Cardiocrinum cathayanumFruitLushan, Jiangxi
(48)Chlorophytum comosumHerbLushan, Jiangxi
(49)Convallaria majalisLeafBozhou, Anhui
(50)Disporopsis asperaHerbZhangjiajie, Hunan
(51)Disporopsis asperaLeafShanghai
(52)Disporopsis fuscopictaRootBozhou, Anhui
(53)Disporopsis pernyiHerbLushan, Jiangxi
(54)Disporum bodinieriHerbLushan, Jiangxi
(55)Disporum calcaratumHerbZhangjiajie, Hunan
(56)Disporum sessileHerbLushan, Jiangxi
(57)Fritillaria thunbergiiStemShanghai
(58)Fritillaria cirrhosaStemShanghai
(59)Fritillaria cirrhosa var. ecirrhosaStemShanghai
(60)Fritillaria pallidifloraFlowerBozhou, Anhui
(61)Hemerocallis fulvaFlowerShijiazhuang, Hebei
(62)Hemerocallis minorRootShijiazhuang, Hebei
(63)Hemerocallis fulvaRootShanghai
(64)Heterosmilax chinensisRootLushan, Jiangxi
(65)Heterosmilax japoniaLeafJinyunshan, Chongqing
(66)Heterosmilax yunnanensisLeafJingzhou, Hubei
(67)Hosta plantagineaFlowerBozhou, Anhui
(68)Hosta plantagineaRootChengdu, Sichuan
(69)Hosta ventricosaHerbShanghai
(70)Lilium browniiHerbZhangjiajie, Hunan
(71)Lilium brownii var. viridulumHerbShanghai
(72)Lilium brownii var. viridulumFlowerShijiazhuang, Hebei
(73)Lilium callosumHerbYunwushan, Guangdong
(74)Lilium longiflorumStemEmeishan, Sichuan
(75)Liriope graminifoliaHerbShanghai
(76)Liriope graminifoliaFruitShanghai
(77)Liriope minorHerbShanghai
(78)Liriope platyphyllaHerbLushan, Jiangxi
(79)Liriope platyphyllaFruitShanghai
(80)Liriope spicataHerbLushan, Jiangxi
(81)Notholirion hyacinthinumHerbChengdu, Sichuan
(82)Ophiopogon chingiiRootYunwushan, Guangdong
(83)Ophiopogon intermediusHerbJingzhou, Hubei
(84)Ophiopogon jaburanHerbXishuangbanna, Yunnan
(85)Ophiopogon japonicusRootShanghai
(86)Ophiopogon maireiHerbZhangjiajie, Hunan
(87)Ophiopogon tonkinensisHerbXishuangbanna, Yunnan
(88)Paris chinensisHerbYunwushan, Guangdong
(89)Paris polyphyllaFlowerBozhou, Anhui
(90)Paris polyphyllaRootChengdu, Sichuan
(91)Polygonatum cyrtonemaRootLushan, Jiangxi
(92)Polygonatum cyrtonemaStemLushan, Jiangxi
(93)Polygonatum filipesLeafLushan, Jiangxi
(94)Polygonatum filipesRootLushan, Jiangxi
(95)Polygonatum odoratumRootShanghai
(96)Polygonatum cirrhifoliumRootChengdu, Sichuan
(97)Reineckia carneaHerbBozhou, Anhui
(98)Rohdea japonicaRootBozhou, Anhui
(99)Rohdea japonicaSeedsBozhou, Anhui
(100)Sansevieria trifasciataLeafXishuangbanna, Yunnan
(101)Smilacina henryiHerbZhangjiajie, Hunan

2. Materials and Methods

2.1. Plant Material

The plant materials used in this study were collected from different locations of China. The collected species were identified and authenticated by taxonomists from the Second Military Medical University (China). All plant samples were air-dried and finally ground to a fine powder before further processing.

2.2. Extraction

The medicinal plants used in this study were collected at the different areas in China. All voucher specimens have been deposited at the Lab. of Chemistry and Bioactivity of TCM, Shanghai Jiaotong University. The air dried powder of medicinal plants was extracted with 95% ethanol three times (24 h × 3) at room temperature. The extract was evaporated in vacuo to leave a residue extract, which was measured and dissolved in DMSO as the final concentration of 10 mg/mL, respectively.

2.3. Animals

Male C57BL/6 mice, 6–8 weeks old and weighing approximately 20 g, were purchased from SLACCAS Laboratory Animal Co., Ltd (Shanghai, China). All mice were housed (four to five animals per cage) with a 12/12 h light/dark cycle, with ad libitum access to food and water. The housing, breeding, and animal experiments were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, with procedures approved by the Biological Research Ethics Committee of Shanghai Jiao Tong University.

2.4. Cell Culture

The RAW 264.7 macrophage cell line was obtained from the China Cell Line Bank (Beijing, China). The cells were cultured in DMEM medium supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL) in a 37°C and 5% CO2 incubator. The human cervical carcinoma cell line Hela was transfected with pNF-κB-Luc reporter plasmid, which contains five copies of NF-κB binding sequence (Stratagene, La Jolla, CA). The transfected cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum.

2.5. NF-κB Transactivation Assay

The examination of NF-κB activity was performed by a modification of methods as described previously [7]. HeLa cells expressing NF-κB-Luciferase were seeded in 96-well plates at a density of 1.5 × 104 cells per well. After cells became adherent, they were serum-starved in DMEM without phenol red overnight before screening assay. On the next morning, cells were pretreated with the investigated samples, positive control (parthenolide, 10 μM), or solvent vehicle (0.1% DMSO in culture medium) for 1 h and stimulated with 5 ng/mL TNF-α for 4 h [7]. Afterwards, the cells were lysed with luciferase lysis buffer and the luminescence of the firefly luciferase was measured with the microplate reader (FlexStation 3; Molecular Devices, Silicon Valley, CA, USA).

2.6. The MTT Assay for Cell Viability

Cells were plated overnight in 96-well plate (5 × 103/well). Then, the cells were treated with 0.1% DMSO (vehicle control) or the plant extract samples with various concentrations for 24 h. Following another 4 h incubation with 20 μL of MTT solution (5 mg/mL), the culture supernatant was discarded and 100 μL of DMSO was added to each well to dissolve the formazan crystal. OD absorbance was recorded at 490 nm with the microplate reader (FlexStation 3, Molecular Devices, Silicon Valley, CA, USA).

2.7. Determination of NO Production

RAW 264.7 macrophages were plated in 48-well plate (1.5 × 105/well). After cells became adherent, they were pretreated with the test samples, positive control (parthenolide, 10 μM), or solvent vehicle (0.1% DMSO in culture medium) for 1 h and then stimulated with 100 ng/mL LPS for additional 12 h. The nitrite accumulated in culture medium was measured as an indicator of NO production based on Griess reaction. Briefly, 50 μL of cell culture medium was mixed with 50 μL of Griess reagent (1% sulfanilamide in 5% phosphoric acid, 1%  α-naphthylamide in H2O) in a 96-well plate, incubated at room temperature for 10 min, and then measured at 540 nm using a microplate reader (FlexStation 3, Molecular Devices, Silicon Valley, CA, USA) [8].

2.8. RNA Extraction and Reverse Transcription-Polymerase Chain Reaction (RT-PCR)

RAW 264.7 macrophages were plated in 12-well plate (5 × 105/well). Cells pretreated with the test samples, positive control (parthenolide, 10 μM), or solvent vehicle (0.1% DMSO in culture medium) for 1 h were incubated with 100 ng/mL LPS for additional 4 h. Total RNA was extracted from cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA). Reverse transcription of RNA was performed with the Reverse Transcription System A3500 kit (Promega, Madison, WI) according to the manufacturer’s protocol. Relative quantification of gene expression was performed with SYBR® Green Real-Time PCR Master Mix (TOYOBO, Osaka, Japan) and conducted with the Eppendorf Mastercycler ep realplex (Hauppauge, NY). The following primers were used: TNF-α (5′-TTCTCATTCCTGCTTGTGG-3′; 5′-ACTTGGTGGTTTGCTACG-3′), IL-6 (5′-CTTCTTGGGACTGAT G-3′; 5′-CTGGCTTTGTCTTTCT-3′), and IL-1β (5′-GATCCACACTCTCCAGCTGCA-3′; 5′-CAACCAACAAGTGATATTCTCCATG-3′). The primers for the mouse housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were 5′-CCTTCCGTGTTCCTACC-3′ and 5′-CAACCTGGTCCTCAGTGT A-3′ [9].

2.9. Xylene-Induced Ear Edema in Mice

Xylene-induced ear edema in mice was initiated according to a previously described method [10]. Briefly, the male mice were randomly divided into four groups (/group). Mice were intraperitoneally (i.p.) given twice vehicle, dexamethasone (3 mg/kg), and two doses (250 and 500 mg/kg) of the test sample 12 and 1 h before xylene treatment. After the final administration, ear edema was induced by applying 20 μL of xylene to the outer and inner surface of the right ear. The left ear served as a control. Mice were sacrificed after 1 h by carbon dioxide suffocation, and both ears were removed. 7 mm diameter ear punch biopsies were collected by using a metal punch and weighed. Edema () was defined as the difference in weight (mg) between the right and the left ear sample . The extent of the edema was expressed by percentage of increase in the ear tissue weight (%), using the following formula [10]: percentage of edema .

2.10. Statistical Analysis

The results are expressed as mean ± SEM. Statistical differences were compared with one-way ANOVA. values < 0.05 were considered to be significant. All statistical tests were carried out using the GraphPad Software (California, USA).

3. Results

3.1. Inhibitory Effects of the Chinese Medicinal Plant Extracts on TNF-α-Induced NF-κB Activation

In a primary screening, 101 different extracts from 84 plants were assessed for their potential to inhibit TNF-α induced NF-κB activation in Hela cells at the concentrations of 50, 25, and 12.5 μg/mL. As shown in Figure 1(a), 10 out of 101 extracts showed significant NF-κB inhibitory effects at all test concentrations in a dose-dependent manner ( compared with negative control). These 10 extracts were including 1-Rehderodendron macrocarpum (Stem), 2-Styrax suberifolia (Stem), 7-Alangium kurzii (Root), 9-Alangium kurzii var. handelii (Leaf), 27-Cleome gynandra (Seeds), 43-Aspidistra omeiensis (Root), 55-Disporum calcaratum (Herb), 80-Liriope spicata (Herb), 89-Paris polyphylla (Flower), and 90-Paris polyphylla (Root). Twelve out of 101 extracts showed significant NF-κB inhibitory effects ( compared with negative control) at the concentrations of 50 and 25 μg/mL (Figure 1(b)). These extracts were including 6-Alangium chinense ssp. triangulare (Stem), 26-Capparis masaikai (Fruit), 42-Aspidistra omeiensis (Leaf), 46-Cardiocrinum cathayanum (Herb), 50-Disporopsis aspera (Herb), 62-Hemerocallis minor (Root), 77-Liriope minor (Herb), 85-Ophiopogon japonicus (Root), 86-Ophiopogon mairei (Herb), 87-Ophiopogon tonkinensis (Herb), 88-Paris chinensis (Herb), and 101-Smilacina henryi (Herb).

3.2. Effects of the Extracts on Cell Viability

In order to exclude the potential influence of cytotoxicity, the effects of these 22 effective plant extracts at the concentrations of 50, 25, and 12.5 μg/mL along with parthenolide (2.515 μM) on proliferation of Hela cells and RAW 264.7 cells were evaluated using MTT assay. As shown in Table 2, 9 out of 22 extracts did not affect cell viability (>75%) at their effective doses. Parthenolide (10 μM) showed slight effects on cell viability of Hela and RAW 264.7 macrophages (S1 Figure in Supporting Information available online at https://doi.org/10.1155/2017/1231820). These extracts were including 1-Rehderodendron macrocarpum (Stem), 2-Styrax suberifolia (Stem), 7-Alangium kurzii (Root), 26-Capparis masaikai (Fruit), 46-Cardiocrinum cathayanum (Herb), 62-Hemerocallis minor (Root), 77-Liriope minor (Herb), 80-Liriope spicata (Herb), and 87-Ophiopogon tonkinensis (Herb). Therefore, the remaining nine plant extracts were selected for further investigation.


Number Latin name Hela cells Raw 264.7 cells
Viability at 12.5 μg/mL (%)Viability at 25 μg/mL (%)Viability at 50 μg/mL (%)Viability at 12.5 μg/mL (%)Viability at 25 μg/mL (%)Viability at 50 μg/mL (%)

1Rehderodendron macrocarpum105.0 ± 1.2107.0 ± 5.2110.5 ± 2.0122.1 ± 2.4129.6 ± 0.8143.6 ± 2.5
2Styrax suberifolia87.4 ± 2.586.0 ± 1.975.8 ± 1.4110.6 ± 1.399.7 ± 1.681.3 ± 1.9
6Alangium chinense ssp. triangulare103.8 ± 0.3127.9 ± 3.3119.4 ± 3.755.1 ± 2.955.8 ± 4.649.2 ± 3.9
7Alangium kurzii105.4 ± 2.0120.8 ± 2.6127.8 ± 4.6130.8 ± 0.8130.0 ± 2.2134.2 ± 2.4
9Alangium kurzii var. handelii61.7 ± 1.349.1 ± 1.632.2 ± 1.2NTNTNT
26Capparis masaikai110.9 ± 0.3126.7 ± 2.0112.3 ± 3.8123.0 ± 1.3126.0 ± 3.0145.3 ± 1.8
27Cleome gynandra130.6 ± 3.3127.9 ± 4.612.4 ± 0.8132.2 ± 7.0112.0 ± 2.112.1 ± 0.9
42Aspidistra omeiensis25.3 ± 1.809.8 ± 0.910.3 ± 1.0NTNTNT
43Aspidistra omeiensis13.9 ± 1.908.9 ± 0.67.5 ± 0.4NTNTNT
46Cardiocrinum cathayanum84.5 ± 3.592.8 ± 1.585.0 ± 2.3121.2 ± 4.1112.0 ± 0.8113.2 ± 0.9
50Disporopsis aspera87.0 ± 1.743.5 ± 2.48.4 ± 0.2NTNTNT
55Disporum calcaratum88.6 ± 0.885.9 ± 1.481.8 ± 4.580.5 ± 3.975.0 ± 4.868.0 ± 3.0
62Hemerocallis minor121.8 ± 1.877.9 ± 3.071.6 ± 4.6118.2 ± 0.5119.9 ± 3.2101.6 ± 4.7
77Liriope minor128.2 ± 1.9127.6 ± 1.4129.1 ± 2.5151.4 ± 0.4179.2 ± 2.0170.5 ± 3.9
80Liriope spicata103.4 ± 7.184.0 ± 3.864.9 ± 3.5142.4 ± 0.5141.9 ± 1.4136.3 ± 1.5
85Ophiopogon japonicus81.9 ± 1.669.6 ± 2.647.7 ± 2.8NTNTNT
86Ophiopogon mairei112.1 ± 2.593.0 ± 3.656.1 ± 0.988.4 ± 2.389.8 ± 0.676.9 ± 3.4
87Ophiopogon tonkinensis118.9 ± 3.179.5 ± 1.265.5 ± 3.694.0 ± 1.0114.2 ± 4.4104.5 ± 0.3
88Paris chinensis36.3 ± 0.313.0 ± 0.710.0 ± 1.0NTNTNT
89Paris polyphylla10.6 ± 1.47.9 ± 0.45.5 ± 0.1NTNTNT
90Paris polyphylla30.3 ± 0.26.9 ± 0.57.3 ± 0.8NTNTNT
101Smilacina henryi63.0 ± 0.866.7 ± 3.451.3 ± 1.0NTNTNT

Values are means ± standard deviations. NT: not tested.
3.3. Inhibitory Effects of the Extracts on LPS-Induced NO Production in RAW 264.7 Cells

The inhibitory effects of the nine plant extracts on NO production in LPS-stimulated RAW 264.7 cells were assessed. As shown in Figure 2, five extracts, including 46-Cardiocrinum cathayanum (Herb), 62-Hemerocallis minor (Root), 77-Liriope minor (Herb), 80-Liriope spicata (Herb), and 87-Ophiopogon tonkinensis (Herb), showed significant inhibitory effects at both low (12.5 μg/mL) and high concentrations (50 μg/mL).

3.4. Inhibitory Effects of the Plant Extracts on mRNA Expressions of TNF-α, IL-6, and IL-1β in LPS-Stimulated RAW 264.7 Cells

The effects of the above nine extracts active in both NF-κB and NO assays were also assessed at the mRNA level by RT-qPCR. As shown in Figure 3(a), one extract (62-Hemerocallis minor) exhibited the suppressive effect on TNF-α. Four extracts including 1-Rehderodendron macrocarpum (Stem), 2-Styrax suberifolia (Stem), 62-Hemerocallis minor (Root), and 80-Liriope spicata (Herb) and seven extracts including 7-Alangium kurzii (Root), 26-Capparis masaikai (Fruit), 46-Cardiocrinum cathayanum (Herb), 62-Hemerocallis minor (Root), 77-Liriope minor (Herb), 80-Liriope spicata (Herb), and 87-Ophiopogon tonkinensis (Herb) significantly inhibited the mRNA expression of IL-6 and IL-1β, respectively (as shown in Figures 3(b) and 3(c)). Among these effective extracts, the extract 62-Hemerocallis minor (Root) was observed to suppress all the proinflammatory cytokines TNF-α, IL-6, and IL-1β.

3.5. Inhibitory Effects of 62-Hemerocallis Minor (Root) on Xylene-Induced Mice Ear Edema

Hemerocallis minor, which was effective in all the above in vitro assays, was selected to further evaluate the in vivo anti-inflammatory effect. Xylene-induced mice ear edema model was used in this study. Xylene can stimulate local inflammation and then induce edema of tissues. Edema was determined by the increase in ear weight due to an inflammatory challenge. Figure 4 exhibited that Hemerocallis minor extract was effectively inhibiting ear edema in a dose-dependent manner. Compared with the control group, Hemerocallis minor extract at the doses of 250 mg/kg and 500 mg/kg significantly alleviated xylene-induced edema, and the percentage of edema weight was 69% and 42%, respectively. Similarly, dexamethasone (3 mg/kg) led to a percentage of edema weight value of 15%. The results indicated that the Hemerocallis minor extract has a significant anti-acute-inflammation activity.

4. Discussion

Traditional Chinese medicinal plants play a significant role in drug discovery and development. Many have provided the foundation for modern pharmaceuticals and drug leads [11, 12]. In this study, we collected 101 extracts from 84 species of traditional medicinal plants to assess their potential anti-inflammatory effects in a panel of in vitro and in vivo assays. The purpose of this study is to provide more evidence for the plants which have been recorded with uses linked to anti-inflammatory effects and explore more species of undiscovered medicinal plants with anti-inflammatory properties.

NF-κB controls the expression of genes involved in a number of physiological responses, including immune and inflammatory responses [13]. Given NF-κB’s importance in human diseases related to inflammatory disorders and the fact that many anti-inflammatory drugs interfere with NF-κB signaling, we established a screening assay specific for NF-κB activity to discover medicinal plants targeting NF-κB signal pathway [14]. Twenty-two out of 101 extracts exhibit significant inhibitory effects on NF-κB transactivation at concentrations of 25 and 50 μg/mL while ten among them are effective at even lower concentration (12.5 μg/mL). Among these 22 extracts, Paris polyphylla, Liriope spicata, and Cleome gynandra have been historically used in China and have been exploited from the chemical components to biological activities including anti-inflammation and anticancer [1517]. Limited information regarding other species of these medicinal plants has been reported. Our study provides the first evidence for their potential anti-inflammatory effects targeting NF-κB signaling pathway. In the present study, we show that the extracts from different species even from the same genus lead to different pharmacological responses. Different clinical application of extracts from the different species of the same genus or different parts of the same plant may be explained by differences in pharmacological responses induced by them.

Macrophage activation by LPS leads to the phosphorylation, ubiquitination, and subsequent degradation of the inhibitory κB (IκB). This induced degradation of IκBs allows NF-κB to freely enter the nucleus and to induce the production of NO and transcriptions of proinflammatory cytokines including IL-1β, IL-6, and TNF-α, which are important for the inflammatory and immune response [18, 19]. The pharmacological reduction of LPS-inducible inflammatory mediators is regarded as one of the essential conditions to alleviate acute and chronic inflammations caused by activation of macrophages [20]. Therefore, LPS-stimulated macrophage cells provide us with an excellent model for investigating inflammatory response and subsequently for screening anti-inflammatory drugs and their underlying mechanisms [21, 22]. In the present study, the hit extracts found in the preliminary screening with NF-κB assay and without cellular toxicities were further subjected to detect the effects on the level of NO production and TNF-α, IL-1β, and IL-6 mRNA expressions in LPS-stimulated RAW 264.7 macrophages. The nine hit extracts were active in at least one of the subsequently performed in vitro pharmacological test systems, which were including NO production and cytokines mRNA expressions. Hemerocallis minor extract was found to be effective in all in vitro assays and not to affect the cell viability. The extract from Hemerocallis minor also inhibited xylene-induced mice ear edema. Hemerocallis minor, frequently referred to as yellow lily, has been applied in China as food and folk remedy, particularly for heat-clearing and breast mastitis [21, 22]. To our knowledge, it is the first report that Hemerocallis minor may possess possible therapeutic anti-inflammatory properties. Our results might provide a rationale for the traditional use of this plant in China and make it a highly interesting medicinal plant, having the potential to be further explored as anti-inflammatory agents. However further phytochemical and pharmacological studies on Hemerocallis minor remain to be performed.

5. Conclusions

In summary, the present study demonstrates that extracts from nine medicinal plants exhibit properties of anti-inflammatory activity by either suppressing NO production or the major proinflammatory cytokines TNF-α, IL-1β, and IL-6. Hemerocallis minor is the particularly interesting one which is effective in all the in vitro and in vivo assays and has the potential to be developed as anti-inflammatory therapeutics or preventatives.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Authors’ Contributions

Chao Fan and Hui-zi Jin have contributed equally to this work.

Acknowledgments

This work was funded by National Science Foundation of China (81402806). This work was also supported in part by grants from the National Natural Science Foundation of China (Grant 31470856), the Science and Technology Development Fund of Macau (FDCT 026/2016/A1 and 072/2015/A2), and the University of Macau (CPG2015-00018-ICMS).

Supplementary Materials

S1 Figure: Cytotoxicity of parthenolide in RAW 264.7 macrophages and Hela cells. Cells were incubated with parthenolid (2.5, 5, 10 and 15 μM) for 24 h. The cell viability was tested by MTT assay. The data were expressed as mean ± S.E.M.

  1. Supplementary Material

References

  1. R. Medzhitov, “Origin and physiological roles of inflammation,” Nature, vol. 454, no. 7203, pp. 428–435, 2008. View at: Publisher Site | Google Scholar
  2. T. V. A. Tran, C. Malainer, S. Schwaiger et al., “Screening of Vietnamese medicinal plants for NF-κB signaling inhibitors: assessing the activity of flavonoids from the stem bark of Oroxylum indicum,” Journal of Ethnopharmacology, vol. 159, pp. 36–42, 2015. View at: Publisher Site | Google Scholar
  3. T. Lawrence, “The nuclear factor NF-κB pathway in inflammation,” Cold Spring Harbor perspectives in biology, vol. 1, no. 6, Article ID a001651, 2009. View at: Publisher Site | Google Scholar
  4. M. Toi-Scott, C. L. A. Jones, and M. A. Kane, “Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells,” Lung Cancer, vol. 15, no. 3, pp. 341–354, 1996. View at: Publisher Site | Google Scholar
  5. N. Fakhrudin, B. Waltenberger, M. Cabaravdic et al., “Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo,” British Journal of Pharmacology, vol. 171, no. 7, pp. 1676–1686, 2014. View at: Publisher Site | Google Scholar
  6. H.-D. Ma, Y.-R. Deng, Z. Tian, and Z.-X. Lian, “Traditional Chinese medicine and immune regulation,” Clinical Reviews in Allergy and Immunology, vol. 44, no. 3, pp. 229–241, 2013. View at: Publisher Site | Google Scholar
  7. Q. Tian, J. Li, X. Xie et al., “Stereospecific induction of nuclear factor-κB activation by isochamaejasmin,” Molecular Pharmacology, vol. 68, no. 6, pp. 1534–1542, 2005. View at: Publisher Site | Google Scholar
  8. S.-Y. Cheon, K.-S. Chung, E. Jeon, A. Nugroho, H.-J. Park, and H.-J. An, “Anti-inflammatory Activity of Saxifragin via Inhibition of NF-κB Involves Caspase-1 Activation,” Journal of Natural Products, vol. 78, no. 7, pp. 1579–1585, 2015. View at: Publisher Site | Google Scholar
  9. J. Liu, D. Wang, S.-Q. Li, Y. Yu, and R. D. Ye, “Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A,” Journal of Neuroinflammation, vol. 13, article 28, 2016. View at: Publisher Site | Google Scholar
  10. W. Li, H. Huang, Y. Zhang et al., “Anti-inflammatory effect of tetrahydrocoptisine from Corydalis impatiens is a function of possible inhibition of TNF-α, IL-6 and NO production in lipopolysaccharide-stimulated peritoneal macrophages through inhibiting NF-κB activation and MAPK pathway,” European Journal of Pharmacology, vol. 715, no. 1–3, pp. 62–71, 2013. View at: Publisher Site | Google Scholar
  11. G. M. Cragg and D. J. Newman, “Natural products: a continuing source of novel drug leads,” Biochimica et Biophysica Acta—General Subjects, vol. 1830, no. 6, pp. 3670–3695, 2013. View at: Publisher Site | Google Scholar
  12. M. J. Balunas and A. D. Kinghorn, “Drug discovery from medicinal plants,” Life Sciences, vol. 78, no. 5, pp. 431–441, 2005. View at: Publisher Site | Google Scholar
  13. S. L. Doyle and L. A. J. O'Neill, “Toll-like receptors: from the discovery of NFκB to new insights into transcriptional regulations in innate immunity,” Biochemical Pharmacology, vol. 72, no. 9, pp. 1102–1113, 2006. View at: Publisher Site | Google Scholar
  14. H.-F. Zhou, C. Xie, R. Jian et al., “Biflavonoids from caper (Capparis spinosa L.) fruits and their effects in inhibiting NF-kappa B activation,” Journal of Agricultural and Food Chemistry, vol. 59, no. 7, pp. 3060–3065, 2011. View at: Publisher Site | Google Scholar
  15. M.-S. Lee, J. C. Yuet-Wa, S.-K. Kong et al., “Effects of polyphyllin D, a steroidal saponin in Paris polyphylla, in growth inhibition of human breast cancer cells and in xenograft,” Cancer Biology and Therapy, vol. 4, no. 11, pp. 1248–1254, 2005. View at: Publisher Site | Google Scholar
  16. Z.-F. Hu, L.-L. Chen, J. Qi, Y.-H. Wang, H. Zhang, and B.-Y. Yu, “Two new benzofuran derivatives with anti-inflammatory activity from Liriope spicata var. prolifera,” Fitoterapia, vol. 82, no. 2, pp. 190–192, 2011. View at: Publisher Site | Google Scholar
  17. R. T. Narendhirakannan, S. Subramanian, and M. Kandaswamy, “Anti-inflammatory and lysosomal stability actions of Cleome gynandra L. studied in adjuvant induced arthritic rats,” Food and Chemical Toxicology, vol. 45, no. 6, pp. 1001–1012, 2007. View at: Publisher Site | Google Scholar
  18. O.-K. Kwon, M.-Y. Lee, J.-E. Yuk et al., “Anti-inflammatory effects of methanol extracts of the root of Lilium lancifolium on LPS-stimulated Raw264.7 cells,” Journal of Ethnopharmacology, vol. 130, no. 1, pp. 28–34, 2010. View at: Publisher Site | Google Scholar
  19. B. Beutler, “Tlr4: central component of the sole mammalian LPS sensor,” Current Opinion in Immunology, vol. 12, no. 1, pp. 20–26, 2000. View at: Publisher Site | Google Scholar
  20. S. O. Abarikwu, “Kolaviron, a natural flavonoid from the seeds of Garcinia kola, reduces LPS-induced inflammation in macrophages by combined inhibition of IL-6 secretion, and inflammatory transcription factors, ERK1/2, NF-κB, p38, Akt, p-c-JUN and JNK,” Biochimica et Biophysica Acta—General Subjects, vol. 1840, no. 7, pp. 2373–2381, 2014. View at: Publisher Site | Google Scholar
  21. W.-C. Chen, C.-S. Yen, W.-J. Huang, Y.-F. Hsu, G. Ou, and M.-J. Hsu, “WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-inflammatory properties via MKP-1 in LPS-stimulated RAW264.7 macrophages,” British Journal of Pharmacology, vol. 172, no. 7, pp. 1894–1908, 2015. View at: Publisher Site | Google Scholar
  22. W.-Z. Xie, C.-S. Fan, and Z.-Y. Zhu, “The national assembly of Chinese herbal medicine,” People's Medical Publishing House, pp. 603–604, 1978. View at: Google Scholar

Copyright © 2017 Chao Fan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1761 Views | 1089 Downloads | 2 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.